Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1379090 | Bioorganic & Medicinal Chemistry Letters | 2006 | 6 Pages |
Abstract
Beginning with a moderately potent PPARγ agonist 9, a series of potent and highly subtype-selective PPARα agonists was identified through a systematic SAR study. Based on the results of the efficacy studies in the hamster and dog models of dyslipidemia and the desired pharmacokinetic data, the optimized compound 39 was selected for further profiling.
Graphical abstractA series of potent and subtype-selective PPARα agonists was synthesized. The optimized compound 39 was selected for further profiling.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Ranjit C. Desai, Edward Metzger, Conrad Santini, Peter T. Meinke, James V. Heck, Joel P. Berger, Karen L. MacNaul, Tian-quan Cai, Samuel D. Wright, Arun Agrawal, David E. Moller, Soumya P. Sahoo,